Cargando…
Select Biomarkers on the Day of Anterior Cruciate Ligament Reconstruction Predict Poor Patient-Reported Outcomes at 2-Year Follow-Up: A Pilot Study
BACKGROUND: The majority of patients develop posttraumatic osteoarthritis within 15 years of anterior cruciate ligament (ACL) injury. Inflammatory and chondrodegenerative biomarkers have been associated with both pain and the progression of osteoarthritis; however, it remains unclear if preoperative...
Autores principales: | Lattermann, Christian, Conley, Caitlin E.-W., Johnson, Darren L., Reinke, Emily K., Huston, Laura J., Huebner, Janet L., Chou, Ching-Heng, Kraus, Virginia B., Spindler, Kurt P., Jacobs, Cale A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076965/ https://www.ncbi.nlm.nih.gov/pubmed/30105266 http://dx.doi.org/10.1155/2018/9387809 |
Ejemplares similares
-
Increased Effusion Synovitis for Those With a Dysregulated Inflammatory Response After an Anterior Cruciate Ligament Injury
por: Jacobs, Cale A, et al.
Publicado: (2023) -
Biomarkers on the Day of ACL Reconstruction and Sex Predictive of Knee-related Quality of Life at 2-year Follow-up
por: Lattermann, Christian, et al.
Publicado: (2017) -
Synovial Fluid Inflammatory Profiles did not Differ between Isolated Anterior Cruciate Ligament and Multi-ligament Knee Injuries
por: Jacobs, Cale A., et al.
Publicado: (2023) -
Comparison of Physical Therapy Utilization and Motion-Related Re-operations Between Isolated Anterior Cruciate Ligament and Multi-Ligament Knee Injuries
por: Jacobs, Cale A, et al.
Publicado: (2023) -
MOntelukast as a potential CHondroprotective treatment following Anterior cruciate ligament reconstruction (MOCHA Trial): study protocol for a double-blind, randomized, placebo-controlled clinical trial
por: Jacobs, Cale A., et al.
Publicado: (2022)